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Evaluating the Guideline Enhancement Tool
(GET): an innovative clinical training tool to
enhance the use of hypertension guidelines in
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Abstract
Background: This project aims to evaluate the effectiveness of an innovative educational intervention in enhancing
clinical decision making related to the management of hypertension in general practice. The relatively low level of
uptake of clinical practice guidelines by clinicians is widely recognised as a problem that impacts on clinical outcomes.
This project addresses this problem with a focus on hypertension guidelines. Hypertension is the most frequently
managed problem in general practice but evidence suggests that management of Hypertension in general practice is
sub-optimal.
Methods/design: This study will explore the effectiveness of an educational intervention named the ‘Guideline
Enhancement Tool (GET)’. The intervention is designed to guide clinicians through a systematic process of considering
key decision points related to the management of hypertension and provides a mechanism for clinicians to engage
with the hypertension clinical guidelines.
The intervention will be administered within the Australian General Practice Training program, via one of the regional
training providers. Two cohorts of trainees will participate as the intervention and delayed intervention groups.
This process is expected to improve clinicians’ engagement with the hypertension guidelines in particular, and enhance
their clinical reasoning abilities in general. The effectiveness of the intervention in improving clinical reasoning will be
evaluated using the ‘Script Concordance Test’.
Discussion: The study design presented in this protocol aims to achieve two major outcomes. Firstly, the trial and
evaluation of the educational intervention can lead to the development of a validated clinical education strategy that
can be used in GP training to enhance the decision-making processes related to the management of hypertension.
This has the potential to be adapted to other clinical conditions and training programs and can benefit clinicians
in their clinical decision-making. Secondly, the study explores features that influence the effective use of clinical
practice guidelines. The study thus addresses a significant problem in clinical education.
Keywords: Clinical decision making, Clinical reasoning, Clinical practice guidelines, Guideline Enhancement Tool (GET),
General practice training, Clinical education, Hypertension
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Background
The relatively low levels of uptake of clinical practice
guidelines is widely recognised in the literature as a
practical problem impacting on clinical outcomes [1,2].
This study aims to evaluate the impact of a clinical
education intervention designed to enhance the use of
clinical practice guidelines and develop clinicians’ clinical
reasoning abilities. The study focusses on hypertension
guidelines and their use within general practice in
Australia.
Hypertension is an important health problem in the
Australian general practice setting. Data from the Aus-
tralian Diabetes, Obesity and Lifestyle (AusDiab) study
showed that 28.6% of adults aged 25 years or over had
hypertension [3]. The data collected from the Bettering
the Evaluation and Care of Health (BEACH) program
between January 2009 and 2010 showed hypertension to
be the most frequently managed problem in general
practice, accounting for 5.7% of all managed problems [4].
Despite the high prevalence and importance of hyper-
tension in the GP setting, there is evidence of a signifi-
cant deficit in the treatment of hypertension. Data from
the AusDiab study showed that only 45.8% of patients
with hypertension are being treated [3]. A retrospective
study that examined the care provided to 1154 adult
Australians showed that of the 4700 clinical encounters
involving the management of hypertension, patients
received appropriate care only 72% of the time [5].
The reasons for this evidence-practice gap are multi-
factorial: while drug-related and patient related factors
play a role, health professional-related factors are very
important [6,7]. The latter includes difficulties faced by
GPs in making management decisions that accommo-
date patient differences and preferences [8].
This issue was further highlighted in a recent study in-
volving focus groups of Australian GPs that found that
the desire to provide comprehensive, holistic care that
incorporates patient concerns and context into manage-
ment decisions was an important factor that affected the
management of hypertensive patients [6]. There is
therefore a clear need to recognise and respond to the
contextual factors that influence clinical decision-
making, and to consider these contextual factors in
developing and implementing clinical guidelines.
The proposed project aims to address this need
through an innovative clinical educational intervention
and evaluate its feasibility and effectiveness. The inter-
vention is named the ‘Guideline Enhancement Tool’ (GET)
and is designed to:
1. Promote effective use of hypertension guidelines by
General Practitioners.
2. Develop clinicians’ decision-making processes related
to the management of hypertension.
3. Enable the consideration of contextual factors that
influence clinical decisions, and encourage
participants to make recommendations for tailoring
the guidelines to better suit General Practice contexts.
The design of the GET was informed by previous re-
search [9-11], which highlighted the factors that influ-
ence the incorporation of updated evidence to practice.
The influences were explored from the perspectives of
translational research, and can be framed within the the-
oretical bases of clinical reasoning [12], evidence-based-
medicine [13], and the theory of reasoned action [14].
The clinical education strategy facilitates clinicians’ cog-
nitive engagement with these influences to achieve more
effective uptake of guidelines.
Methods and design
Study design
This is a non-randomised, delayed intervention study
design. The study is not randomised since the educa-
tional intervention will be administered in groups and
randomising groups will require unrealistic sample size.
However, using repeated measures and a delayed inter-
vention design provides an optimal solution without
compromising the study quality. Such a design is prefer-
able for evaluation of the educational intervention since
all participants receive the intervention and the design
enables measure of progress across and within groups,
including control for possible (although unlikely) differ-
ences between groups at the starting time.
Clinicians participating in this study will be recruited
from a population of general practice registrars who are
undergoing GPTerm1 or GPTerm2 stages of training at
GP Synergy (a major provider of general practice train-
ing in Australia), at two training sites. Participants from
site A will be the ‘early intervention group’ while the
group at site B will be the ‘delayed intervention group’.
The two interventions will be identical and will differ
only by the time of implementation. Participants will
undergo evaluations of clinical reasoning (based on the
Script Concordance Test (SCT) [15] upon commence-
ment of project (Time Point 1: before the early interven-
tion), immediately after the early intervention and before
the delayed intervention starts (Time Point 2), and at
the end of the delayed intervention (Time Point 3).
The impact of the intervention will be measured by
comparing the progress each group makes (changes in
SCT scores) over each intervention period.
Sample size
Two systematic reviews suggest that the effect size on
SCT between resident doctors and expert doctors ranged
0–3.2; typically around 1 and the effect of educational
interventions such as Educational meetings/interactive
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educational sessions was d > 1 [16,17]. Based on those
studies, we expect that the intervention will yield an effect
size of d ≥ 1.0 measured by the differences in the SCT
results between the intervention and the control groups
between Time Point 1 and Time Point 2. A similar
increase is expected for the delayed intervention group
between Time Point 2 and Time Point 3. Therefore, a
sample size of 34 clinicians (17 intervention & 17 control)
will have 80% power to detect an effect size of d = 1 (one sd.)
with an alpha of 0.05 (two sides) [18].
The educational intervention
The GET is a clinical educational instrument that has
been developed by a team at UNSW Medicine, Australia.
It is structured to facilitate a two stage process of
engagement. Each stage (requiring approx. 30–45 mins)
is designed to fit within existing workshop style GP
training sessions. The two stages are based on two in-
struments (A&B) that have been designed to guide clini-
cians’ engagement with hypertension guidelines and the
key decision points in managing hypertension. The GET
will be supplemented by a final panel discussion with
experts (experienced general practitioners and a car-
diologist) which will enable participants to discuss any
concerns and clarify any issues that arises out of their
engagement with the GET. This discussion, drawing on
participant experiences of the usefulness of the guide-
lines, also aims to develop recommendations to enhance
the usability of the existing guidelines.
The first stage instrument (A) is based on a straight-
forward hypertension patient presentation, devoid of any
complicating contextual factors. This stage provides a
framework for clinicians to critically evaluate their deci-
sions in relation to such a hypertension presentation.
This stage will focus clinicians on the ‘key decision
points’ relevant to the ideal management of such an un-
complicated patient presentation, and will facilitate clini-
cians’ engagement with hypertension guidelines.
The second stage instrument (B) will be based on a
typical patient presentation in a general practice setting,
including contextual influences related to patients, prac-
tice limitations and time pressure considerations. This
stage will provide a guide to the key decision points that
need to be considered by the clinicians, with a frame-
work to identify and articulate the reasons for their deci-
sions in relation to the key decision points. This process
will also provide a mechanism for clinicians to identify
specific contextual factors that influence their decisions.
It is envisaged that this two stage process will not only
enhance clinician engagement with hypertension guide-
lines, but will also enhance their clinical decision making
skills.
The second stage instrument (B) also encourages clini-
cians to reflect on contextual issues particular to the
management of hypertension in general practice, and
allows them to suggest potential modifications to the
guidelines. This is an important contribution to the
process of continuously improving the quality of clinical
practice guidelines, in order to meet conditions or con-
texts which might have been overlooked or have become
outdated.
The final expert panel discussion will provide an oppor-
tunity for these suggestions to be discussed with relevant
experts and peers, in order to develop evidence-based,
contextually appropriate, consensus guidelines. This will
address a commonly identified issue that impacts on the
uptake of guidelines: the perceived ‘top-down’ nature of
guidelines and accompanying interventions to promote
their use, and the limited involvement of end-user clini-
cians in the process of guideline development [17-19].
The GET will be reviewed by senior GPs and will be
trialled on GPs and GP trainees (who have progressed
beyond the participants’ stage of training). Feedback
from this process will be systematically collected and
used to inform further refinements if required.
Measures
The script concordance test (SCT) is a test designed to
assess examinees’ organisation of knowledge for applica-
tion in clinical decisions [15]. The organisation of know-
ledge is named a script. This written test is based on
authentic clinical scenarios that form the basis for test
items. The test items are categorised as diagnostic, investi-
gative or treatment options and examinees are required to
rate their agreement with the provided response options
based on a combination of clinical information that is pro-
vided [15]. While it is a relatively new assessment method,
the SCT is well established in the medical education litera-
ture as a tool with good psychometric properties and good
face validity for assessment of clinical decision-making
competence. It is expected that the SCT will enable the
evaluation of the impact of the GET on developing clinical
reasoning skills.
Prior to commencement of the study, the SCT items
will be reviewed by the project team that includes expe-
rienced GPs and medical educators. An SCT scoring
panel of experienced GPs will be established to ensure
scoring that is relevant to the GP trainee context.
Participating registrars will also be invited to partici-
pate in semi-structured qualitative interviews that will
take about 20–30 minutes, to obtain their views on the
effectiveness and feasibility of GET.
Written informed consent will be obtained from par-
ticipants, using two ‘Participant Information & Consent
Forms’ approved by the Human Research Ethics Panel of
UNSW Australia (Approval ID: 2014-7-26). Informed
written consent will thus be obtained for both the survey
stage and the interview stage of the study.
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Statistical analysis
The main analyses in this study will employ Analysis of
Variance (ANOVA). (a) Factorial ANOVA will be used
to compare the two groups at Time Point 1 and identify
possible differences on SCT scores across groups; (b)
One-way repeated measure ANOVA will be used to
measure the impact of the intervention by comparing
differences in SCT scores within individuals and across
groups between Time Point 1–2 and between Time
Point 2–3. This analysis is appropriate as it allows iden-
tifying the source for the change in the SCT scores
(intervention, initial level of competence or errors [20],
and testing the hypothesis that the change in the SCT
was made by the intervention. We set up a significance
level of p < .05 to demonstrate that the intervention was
successful.
Ethics approval and funding
This study has ethics approval from the Medical and
Community Human Research Ethics Advisory Panel of
the University of New South Wales (Reference Number:
2014-7-26).
The study is funded by a Vanguard Grant (award ID
100260) from the National Heart Foundation of Australia.
Discussion
This project aims to evaluate the effectiveness and feasi-
bility of an innovative clinical educational intervention
named the Guideline Enhancement Tool (GET). The
study will explore the role of the GET in enhancing clin-
ical reasoning in general, and specifically related to the
management of hypertension in general practice. The
project focusses on the important area of clinician en-
gagement with clinical practice guidelines, and includes
a bi-directional format that can lead to the enhancement
of the guidelines.
The project is expected to result in three major
outcomes:
1. Enhanced engagement of general practitioners with
hypertension guidelines
2. A validated clinical education strategy that can be
used in GP training to enhance the decision-making
processes related to the management of hyperten-
sion. This has the potential to be adapted to other
clinical conditions and training programs
3. Recommendations for enhancing the feasibility and
practicality of hypertension guidelines within general
practice contexts
As the clinical education strategy aims to enhance
clinicians’ clinical reasoning abilities, it has the potential
to benefit clinicians in their clinical decision-making
across many areas, beyond the focus of this project. The
educational strategy also serves as a model to inform the
process of future clinical guideline development.
The study design presented in this protocol explores
features that relate to the effective use of clinical practice
guidelines. The study thus addresses a significant prob-
lem in clinical education that can benefit from explor-
ation from a new perspective.
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